LOINC
Version 2.67

62391-8PhenX - lipid profile protocol 040201Trial

Status Information

Status
Trial

Term Description

Measure of plasma lipid levels in blood samples to predict risk for the development of heart attack or to define metabolic syndrome. If the respondent answers "yes" to question 1, then the interviewer will proceed to question 2. The use of lipid-lowering medications must be captured, as the use of medications can have profound and predictable effects on the lipid levels and obscure the levels and phenotype of hyperlipidemia. Lipid profiles involving triglyceride-level measurement should be collected after an 8-12 hour fast. Generally, total cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides should be measured in a laboratory that is certified and referenced to a regional reference laboratory.
Source: Regenstrief LOINC

Panel Hierarchy
Details for each LOINC in Panel LHC-Forms

LOINC Name R/O/C Cardinality Example UCUM Units
62391-8 PhenX - lipid profile protocol 040201
Indent58292-4 Has a doctor or nurse ever said that you have high blood cholesterol?
Indent58293-2 Have you ever taken medication for high blood cholesterol?
Indent58299-9 If yes, At what age did you begin taking medicine for this? a

Fully-Specified Name

Component
PhenX - lipid profile protocol 040201
Property
-
Time
Pt
System
^Patient
Scale
-
Method
PhenX

Additional Names

Short Name
Lipid profile proto

Basic Attributes

Class
PANEL.PHENX
Type
Clinical
First Released
Version 2.36
Last Updated
Version 2.66
Change Reason
Updated the PhenX ID from "PhenX.<ID>" to "PX<ID>" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.; Added the PhenX protocol ID to the Component to clearly define the protocol version for which this panel is based upon.
Panel Type
Panel

Survey Question

Source
PX040201

Reference Information

Type Source Reference
Citation Consensus measures for Phenotypes and Exposures U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung and Blood Institute. Coronary Artery Risk Development in Young Adults (CARDIA) Study. Y20 CARDIA VII. Medical History Form. Page 1. Question 2 (source for question 1 in Protocol Text).
Citation Consensus measures for Phenotypes and Exposures U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung and Blood Institute and Boston University. Framingham Heart Study (FHS). Generation 3. Exam 1. Medical History—Medications. Page 23. No question number provided (source for question 2 in Protocol Text).
Citation Consensus measures for Phenotypes and Exposures U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung and Blood Institute. (2002). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Retrieved on July 21, 2009, from http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf (source for Diagnostic Criteria).

Language Variants Get Info

zh-CNChinese (CHINA)
PhenX - 血脂谱方案 040201:-:时间点:^患者:-:PhenX
ru-RURussian (RUSSIAN FEDERATION)
PhenX - липидный профиль протокол:-:ТчкВрм:^Пациент:-:PhenX

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=62391-8